Whole-Time Director driving finance, operations, and strategic growth at one of the world's largest pharmaceutical companies.
As Whole-Time Director at Sun Pharmaceutical Industries Limited, Sudhir V. Valia plays a pivotal role in shaping the financial and operational direction of one of the world's largest specialty generic pharmaceutical companies. His responsibilities span across multiple domains, reflecting his versatility and depth as a corporate leader.
Sun Pharma, headquartered in Mumbai, India, is the fourth-largest specialty generic pharmaceutical company globally, with operations spanning over 40 countries. Sudhir V. Valia's leadership contributes directly to the company's continued growth, operational efficiency, and market leadership.
Overseeing corporate financial strategy, capital allocation, treasury management, and investor relations for a multi-billion-dollar global operation.
Driving operational excellence across manufacturing, supply chain, and distribution networks that serve markets worldwide.
Ensuring the highest standards of product quality, regulatory compliance, and safety across all manufacturing and R&D facilities.
Leading strategic projects including capacity expansion, new market entry, and organizational transformation initiatives.
Under Sudhir V. Valia's stewardship, Sun Pharma has strengthened its position as a global leader in specialty generics. His approach combines rigorous financial discipline with a forward-looking vision for sustainable growth.
Key contributions include:
"At Sun Pharma, excellence is not a goal — it is a standard. Every decision, every initiative, every investment is measured against the enduring commitment to quality, integrity, and patient-centricity."